Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New application of paeoniflorin in treating achalasia

A technique for achalasia and paeoniflorin, which is applied in the field of medicines for the treatment of achalasia with paeoniflorin, can solve the problems of unclear etiology, lack of effective radical treatment measures, etc., and achieves the advantages of exact curative effect, improved compliance, and safe and effective treatment. Effect

Inactive Publication Date: 2017-05-31
FOURTH MILITARY MEDICAL UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The etiology of the disease is unclear, and there is still no effective cure

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New application of paeoniflorin in treating achalasia
  • New application of paeoniflorin in treating achalasia
  • New application of paeoniflorin in treating achalasia

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0031] 1. General information

[0032] The inventor collected a total of 76 outpatients with esophageal achalasia from September 2013 to April 2014, aged 22-49 years, and the course of disease was 0.2-5 years. Randomly divided into: a treatment group of 50 cases, a blank group of 26 cases. There was no significant difference in age, condition and other data between the two groups, and they were comparable.

example 2

[0047] 1. General information

[0048] The inventor also selected 55 outpatients in our hospital and randomly divided them into two groups. The treatment group consisted of 30 cases, 15 males and 15 females; aged 20 to 50 years, with an average of 32 years old. The control group consisted of 25 cases, including 15 males and 10 females; aged 20 to 40 years, with an average of 32 years old. Both groups had typical clinical manifestations and were diagnosed by swallowing time measurement and gastroscopy. There was no significant difference in general data between the two groups and were comparable.

[0049] 2. Treatment method

[0050]The control group was given Mosapride Tablets 5 mg, 3 times a day, orally before meals; Nifedipine 10 mg, orally 3 times a day. 4 weeks is a course of treatment. The treatment group was given the capsules prepared by the present invention, once in the morning and evening, 3 capsules / time, and 30 days was a course of treatment.

[0051] 3. Effi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medical new application of paeoniflorin, that is, an application of the paeoniflorin to esophageal achalasia. The purified paeoniflorin extracted from paeonia lactiflora has the obvious therapeutical effect on dysphagia, food regurgitation and chest pains of a patient suffering from the esophageal achalasia, and can improve concomitant symptoms of weight losing and the like of the patient. Common dosage forms, prepared by taking the paeoniflorin as main components, of capsules, tableting agents, granules and the like can be used for treating the esophageal achalasia. The dosage range for clinically curing the esophageal achalasia is 2 to 6mg / kg, and the optimal dosage is 4.3mg / kg. The application is definite in curative effect, small in toxic and side effects, low in cost and capable of improving the compliance of the patient suffering from the esophageal achalasia.

Description

[0001] Technical field [0002] The invention belongs to a medicine for treating achalasia of the cardia, in particular to a medicine for treating achalasia of the cardia by extracting paeoniflorin from Chinese herbal medicine peony. Background technique [0003] Achalasia is a common esophageal motility disorder. Primary achalasia is characterized by increased lower esophageal sphincter (LES) tension, loss of normal distal esophageal peristalsis, and LES relaxation disturbance during swallowing. The clinical manifestations are Dysphagia, regurgitation, and chest pain may be accompanied by weight loss and recurrent lung infections. The etiology of the disease is unclear, and there is still no effective cure. [0004] Esophageal achalasia is characterized by lack of peristalsis in the esophagus, high pressure in the lower esophageal sphincter, and abnormal relaxation during swallowing, which prevents food from entering the stomach smoothly. The initial manifestations are obst...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61P1/00
Inventor 李纪鹏孙纪元陈文平李云龙贺奋飞李耀辉
Owner FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com